Massive Mobilization of AML Cells into Circulation by Disruption of Leukemia/Stroma Cell Interactions Using CXCR4 Antagonist AMD3100: First Evidence in Patients and Potential for Abolishing Bone Marrow Microenvironment-Mediated Resistance.
暂无分享,去创建一个
E. Estey | M. Konopleva | M. Andreeff | L. Medeiros | T. McQueen | Z. Zeng | G. Bridger | G. Calandra | R. Champlin | S. Konoplev | J. McCarty | Yue-xi Shi | Rui-yu Wang | S. Elkins